Ls Investment Advisors Has Upped By $1.02 Million Its Quest Diagnostics (DGX) Position; Cousins Properties Has 1.64 Sentiment

September 12, 2017 - By marketbeat

Cousins Properties Incorporated is a self-administered and self-managed real estate investment trust. The company has market cap of $3.91 billion. The Company’s divisions include Office, Mixed-Use, Other, Atlanta, Austin, Charlotte, Orlando, Tampa, Phoenix and Other. It has a 16.38 P/E ratio. It develops, acquires, leases, manages and owns primarily Class A office properties and opportunistic mixed-use developments in Sunbelt markets with a focus on Georgia, Texas and North Carolina.

Ls Investment Advisors Llc increased Quest Diagnostics Inc (DGX) stake by 143.7% reported in 2016Q4 SEC filing. Ls Investment Advisors Llc acquired 11,193 shares as Quest Diagnostics Inc (DGX)’s stock rose 10.72%. The Ls Investment Advisors Llc holds 18,982 shares with $1.74 million value, up from 7,789 last quarter. Quest Diagnostics Inc now has $14.70B valuation. The stock declined 0.43% or $0.46 reaching $107.77 on the news. About 117,590 shares traded. Quest Diagnostics Inc (NYSE:DGX) has risen 39.04% since September 12, 2016 and is uptrending. It has outperformed by 22.34% the S&P500.

About 692,455 shares traded. Cousins Properties Inc (CUZ) has risen 17.13% since September 12, 2016 and is uptrending. It has outperformed by 0.43% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 6 insider sales for $388,284 activity.

Tpg Group Holdings (Sbs) Advisors Inc. holds 3.55% of its portfolio in Cousins Properties Inc for 38.57 million shares. Real Estate Management Services Llc owns 1.21 million shares or 2.04% of their US portfolio. Moreover, Schneider Capital Management Corp has 1.49% invested in the company for 1.02 million shares. The Japan-based Daiwa Securities Group Inc. has invested 1.01% in the stock. Chilton Capital Management Llc, a Texas-based fund reported 979,956 shares.

Among 18 analysts covering Quest Diagnostics (NYSE:DGX), 8 have Buy rating, 2 Sell and 8 Hold. Therefore 44% are positive. Quest Diagnostics had 37 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Quest Diagnostics Inc (NYSE:DGX) has “Buy” rating given on Tuesday, July 25 by Bank of America. As per Wednesday, April 26, the company rating was maintained by Mizuho. The rating was initiated by Citigroup with “Neutral” on Friday, September 9. The firm earned “Buy” rating on Tuesday, January 3 by Mizuho. The rating was maintained by RBC Capital Markets with “Sector Perform” on Friday, January 29. The rating was maintained by Morgan Stanley on Thursday, August 10 with “Underweight”. Raymond James upgraded the shares of DGX in report on Friday, April 21 to “Outperform” rating. Zacks upgraded the shares of DGX in report on Tuesday, August 18 to “Hold” rating. The rating was maintained by Canaccord Genuity with “Buy” on Sunday, June 11. The rating was maintained by Raymond James with “Buy” on Monday, June 26.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com